This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

2 Aug 2011

Sanofi Reports Sales Growth of 6.9%

Sanofi announced its financial results for the second quarter of 2011 with total sales growth of 6.9% to €8,349 million.

Sanofi announced last week its financial results for the second quarter of 2011 with strong growth following the acquisition of Genzyme.


Sanofi's total sales grew 6.9% to €8,349 million. Excluding Genzyme, sales were down 4.0% reflecting €778 million of sales lost due to generic competition vs. Q2 2010. Growth platforms grew by 9.5% and including Genzyme accounted for 65.2% of total sales.


In the second quarter of 2011, Sanofi generated net sales of €8,349 million, up 0.5% on a reported basis. Exchange rate movements had a negative effect of 6.4 percentage points, of which more than 70% was due to the weakening of the U.S. dollar versus the Euro. Various currencies from Emerging Markets (notably the Venezuelan Bolivar, Chinese Yuan

Related News